Betaderm and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Betaderm (betamethasone valerate) and Ranitidine (ranitidine). Common drug interactions include urinary tract infection among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Betaderm and Ranitidine. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Betaderm?

Betaderm has active ingredients of betamethasone valerate. eHealthMe is studying from 1,472 Betaderm users. Check the latest studies of Betaderm.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

On Jul, 11, 2026

53 people who take Betaderm and Ranitidine together, and have interactions are studied.

Betaderm and Ranitidine drug interactions.

What are the common drug interactions of Betaderm and Ranitidine, by gender? *:

female:

Urinary tract infection
Asthenia (weakness)
Leukopenia (less number of white blood cells in blood)
Eyelid disorder
Impaired self-care
Psychiatric decompensation (worsening of symptoms to the state of a serious mental disorder)
Abdominal pain upper
Back pain
Fatigue (feeling of tiredness)
Feeding disorder (when children refuse to eat certain food groups)

male:

Nausea (feeling of having an urge to vomit)
Weight decreased
Bruxism (habitual grinding of the teeth, typically during sleep)
Dizziness
Drug level above therapeutic
Dyspnoea (difficult or laboured respiration)
Dysuria (painful or difficult urination)
Facial pain
Fatigue (feeling of tiredness)
Frequent bowel movements

What are the common drug interactions of Betaderm and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Weight decreased
Weight increased
Abdominal distension
Abdominal pain
Asthenia (weakness)
Bowel movement irregularity
C-reactive protein increased
Drug level above therapeutic
Fatigue (feeling of tiredness)
Frequent bowel movements

30-39:

Back pain
Bruxism (habitual grinding of the teeth, typically during sleep)
Dizziness
Dysuria (painful or difficult urination)
Epiglottic oedema (swelling and inflammation of the epiglottis)
Facial pain
Hypotension (abnormally low blood pressure)
Micturition urgency (urgency to pass the urine)
Muscular weakness (muscle weakness)
Pain in extremity

40-49:

Asthenia (weakness)
Blood thyroid stimulating hormone decreased
Colitis ulcerative (inflammation of colon with ulcer)
Communication disorder (speech and language disorder)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Dizziness
Feeling guilty
Iron deficiency anaemia
Rectal haemorrhage (bleeding from anus)
Thyroxine free decreased

50-59:

Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Rectal haemorrhage (bleeding from anus)
Abdominal distension
Arthralgia (joint pain)
Crying
Emotional disorder
Malaise (a feeling of general discomfort or uneasiness)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Neck pain

60+:

Constipation
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Psychiatric decompensation (worsening of symptoms to the state of a serious mental disorder)
Granulocytopenia (lack of granulocyte)
Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
Arteriosclerosis (thickening and hardening of arteries)
Blood creatine phosphokinase increased
Blood potassium increased
C-reactive protein increased

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 26 people, 49.06%
High Blood Cholesterol: 7 people, 13.21%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.43%
Pain: 4 people, 7.55%
Abdominal Discomfort: 4 people, 7.55%
Skin Disorder (skin disease): 3 people, 5.66%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 5.66%
Rashes (redness): 3 people, 5.66%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.66%
Muscle Spasms (muscle contraction): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Betaderm and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously